Anilazine: Target Organs and Levels of Evidence for TR-104
Bioassay of Anilazine for Possible Carcinogenicity (CASRN 101-05-3)
| Chemical (Study Title) CASRN  | 
			Peer Review Date | Route/Exposure Levels | Study Laboratory | 
|---|---|---|---|
| Anilazine 101-05-3  | 
			06/29/1978 | Dosed-Feed 0,500,1000 PPM  | 
			Gulf South Research Institute |